146 related articles for article (PubMed ID: 15847987)
21. [Drug release and biocompatibility of cyclosporine A drug delivery system implanting into the anterior chamber].
Liu ZS; Xie LX; Shi WY; Li SW; Cai Q; Bei JZ; Wang SG
Zhonghua Yan Ke Za Zhi; 2004 Feb; 40(2):108-12. PubMed ID: 15059564
[TBL] [Abstract][Full Text] [Related]
22. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.
Di Tommaso C; Torriglia A; Furrer P; Behar-Cohen F; Gurny R; Möller M
Int J Pharm; 2011 Sep; 416(2):515-24. PubMed ID: 21219997
[TBL] [Abstract][Full Text] [Related]
23. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.
Chen Y; Lu Y; Zhong Y; Wang Q; Wu W; Gao S
J Drug Target; 2012 Dec; 20(10):856-63. PubMed ID: 23050903
[TBL] [Abstract][Full Text] [Related]
24. Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications.
Guillaumie F; Furrer P; Felt-Baeyens O; Fuhlendorff BL; Nymand S; Westh P; Gurny R; Schwach-Abdellaoui K
J Biomed Mater Res A; 2010 Mar; 92(4):1421-30. PubMed ID: 19358259
[TBL] [Abstract][Full Text] [Related]
25. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
27. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.
Gilger BC; Salmon JH; Wilkie DA; Cruysberg LP; Kim J; Hayat M; Kim H; Kim S; Yuan P; Lee SS; Harrington SM; Murray PR; Edelhauser HF; Csaky KG; Robinson MR
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2596-605. PubMed ID: 16723476
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients.
Hendriks MP; Blijlevens NM; Schattenberg AV; Burger DM; Donnelly JP
Bone Marrow Transplant; 2006 Oct; 38(7):521-5. PubMed ID: 16981000
[TBL] [Abstract][Full Text] [Related]
29. Ocular absorption behavior of palmitoyl tilisolol, an amphiphilic prodrug of tilisolol, for ocular drug delivery.
Kawakami S; Nishida K; Mukai T; Yamamura K; Kobayashi K; Sakaeda T; Nakamura J; Nakashima M; Sasaki H
J Pharm Sci; 2001 Dec; 90(12):2113-20. PubMed ID: 11745770
[TBL] [Abstract][Full Text] [Related]
30. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
Weiss SL; Kramer WG
J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
[No Abstract] [Full Text] [Related]
31. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
[TBL] [Abstract][Full Text] [Related]
32. Water soluble cyclosporine monomethoxy poly(ethyleneglycol) conjugates as potential prodrugs.
Cho H; Chung Y
Arch Pharm Res; 2004 Jun; 27(6):662-9. PubMed ID: 15283470
[TBL] [Abstract][Full Text] [Related]
33. Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
Palanki MS; Akiyama H; Campochiaro P; Cao J; Chow CP; Dellamary L; Doukas J; Fine R; Gritzen C; Hood JD; Hu S; Kachi S; Kang X; Klebansky B; Kousba A; Lohse D; Mak CC; Martin M; McPherson A; Pathak VP; Renick J; Soll R; Umeda N; Yee S; Yokoi K; Zeng B; Zhu H; Noronha G
J Med Chem; 2008 Mar; 51(6):1546-59. PubMed ID: 18311895
[TBL] [Abstract][Full Text] [Related]
34. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs.
Agarwal P; Scherer D; Günther B; Rupenthal ID
Int J Pharm; 2018 Mar; 538(1-2):119-129. PubMed ID: 29339249
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
Rao SN; Rao RD
Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
[TBL] [Abstract][Full Text] [Related]
36. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
37. Self-assembling colloidal system for the ocular administration of cyclosporine A.
Luschmann C; Tessmar J; Schoeberl S; Strauß O; Luschmann K; Goepferich A
Cornea; 2014 Jan; 33(1):77-81. PubMed ID: 24162754
[TBL] [Abstract][Full Text] [Related]
38. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
Liu XL; Tang J; Song J; He J; Xu P; Peng WX
Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
[TBL] [Abstract][Full Text] [Related]
39. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
Anand BS; Katragadda S; Gunda S; Mitra AK
Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.
Yenice I; Mocan MC; Palaska E; Bochot A; Bilensoy E; Vural I; Irkeç M; Hincal AA
Exp Eye Res; 2008 Sep; 87(3):162-7. PubMed ID: 18675411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]